Category: association for simulated practice in healthcare

EMA approves interferon beta treatments, including Rebif (interferon beta-1a), for relapsing MS patients during pregnancy and breastfeeding

Posted on 22 October, 2019 - Industry News

News from Merck

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue

Category: association for simulated practice in healthcare

EMA approves interferon beta treatments, including Rebif (interferon beta-1a), for relapsing MS patients during pregnancy and breastfeeding

Recent News

Categories

WARNING